Assistant Clinical Professor of Medicine, Tulane University
Nephrology
Dr. Jill S. Lindberg, MD
|
|
Give Review
Jill Lindberg is an expert in the field of Nephrology. She studied medicine at University of Illinois College of Medicine. She received 3 awards: "Regional Top Doctor", "Meaningful Use Stage 1 Certification" and "Super Doctor". Jill S. Lindberg, MD is also published. She has 56 publications published. The lastest publication: "Agglomeration inhibition reflected stone-forming activity during long-term potassium citrate therapy in calcium stone formers.' Jill Lindberg is registered with Medicare and accepts Medicare payments.
Publications
- Calcimimetics: a new tool for management of hyperparathyroidism and renal osteodystrophy in patients with chronic Kidney disease.
- Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary Hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, mult...
- Impact of multidisciplinary, early Renal education on vascular access placement.
- Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic Kidney disease stages 3 and 4.
- Introduction. Renal osteodystrophy.
- On the evolving nature of understanding dialysis-related Disorders.
- Long-term combined treatment with thiazide and potassium citrate in nephrolithiasis does not lead to hypokalemia or hypochloremic metabolic Alkalosis.
- The calcimimetic AMG 073 reduces parathyroid hormone and Calcium x phosphorus in secondary hyperparathyroidism.
- How should hyperphosphatemia be managed in dialysis patients?
- Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients.
- Estrogen replacement increased the citrate and Calcium excretion rates in postmenopausal women with recurrent urolithiasis.
- Management of suspected hemodialysis graft dysfunction: usefulness of diagnostic US.
- Gastrointestinal tolerance of oral Calcium supplements.
- Nocodazole treatment of CV-1 cells enhances nuclear/perinuclear accumulation of lipid-DNA complexes and increases gene expression.
- Surgery for neoplastic changes in ulcerative colitis--can limited resection be justified? Outcome for patients who underwent limited surgery.
- Septic arthritis of the knee: a 10-year review and long-term follow-up using a new scoring system.
- Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study.
- Comparison of hypertonic saline solutions and dextran in dialysis-induced Hypotension.
- Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in Renal allografts.
- Fibrillary glomeruloNephritis: a case report.
- Lysine vasopressin in the treatment of refractory hemodialysis-induced Hypotension.
- The risks of exercise.
- Calcium Oxalate Stone Agglomeration Inhibition [tm] Reflects Renal Stone-Forming Activity.
- Multicenter evaluation of a polytetrafluoroethylene vascular access graft as compared With the expanded polytetrafluoroethylene vascular access graft in hemodialysis a...
- Racial differences in bone mineral density and bone loss among end-stage renal Disease patients.
- Serratia marcescens peritonitis in a patient receiving Chronic ambulatory peritoneal dialysis complicated by osteomyelitis.
- New vitamin D analogs.
- Carnitine therapy is associated With decreased hospital utilization among hemodialysis patients.
- Nontransplant therapy for dialysis-related Amyloidosis.
- Free and total 1,25-dihydroxyvitamin D levels in subjects with renal Disease.
- Peritoneoscopic placement of Swan neck peritoneal dialysis catheters.
- Calcium citrate, a nonaluminum-containing phosphate-binding agent for treatment of CRF.
- Effect of citrate on serum aluminum concentrations in hemodialysis patients: a prospective study.
- The healthy start renal clinic: benefits of tracking and early intervention in pre-end stage renal Disease patients.
- Suppression of parathyroid hormone secretion in hemodialysis patients by a novel vitamin D analogue: 19-nor-1,25-dihydroxyvitamin D2.
- Magnesium bioavailability from Magnesium citrate and Magnesium oxide.
- Research directions: new clinical frontiers.
- A longitudinal study of uremic pruritus in hemodialysis patients.
- Treatment strategies for renal bone Disease.
- Clinical management of dialysis-related carnitine deficiency: three case studies.
- Osteoporosis in end-state renal Disease.
- An innovative approach to temporary hemodialysis vascular access.
- Real-world doxercalciferol treatment in SHPT CKD stage 3 and 4: an analysis of change in iPTH and accordance to KDOQI recommendations.
- Darbepoetin alfa: a new therapy for the management of anaemia associated with chronic Kidney disease.
- Therapy of secondary hyperparathyroidism With 19-nor-1alpha,25-dihydroxyvitamin D2.
- A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal Disease.
- Effect of magnesium citrate and magnesium oxide on the crystallization of Calcium salts in urine: changes produced by food-magnesium interaction.
- Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder. National Kidney Foundation Carnitine Consensus Conference.
- Agglomeration inhibition reflected stone-forming activity during long-term potassium citrate therapy in Calcium stone formers.
- Calcium oxalate stone agglomeration reflects stone-forming activity: citrate inhibition depends on macromolecules larger than 30 kilodalton.
- Urinary Tamm-Horsfall protein increased after potassium citrate therapy in Calcium stone formers.
- Paricalcitol dosing according to body weight or severity of Hyperparathyroidism: a double-blind, multicenter, randomized study.
- 19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis.
- Treatment of anemia with darbepoetin alfa administered de novo once every other week in chronic Kidney disease.
- Coronary and aortic calcifications in patients new to dialysis.
Schools
University Of Illinois College Of Medicine Chicago
Letterman Amc
Brooke Amc
Procedures Preformed
- Arteriovenostomy for Renal Dialysis
- Bone Density Scan
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Alkalosis
- Amyloidosis
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- Regional Top Doctor
- Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
San Antonio Uniformed Services Health Education Consortium -
University of Illinois College of Medicine
Hospital
-
Ochsner Medical Center - Kenner
Drug Facts
| NPI NUMBER | 1952393795 | |
| NPPES Provider LastName | LINDBERG | |
| NPPES Provider FirstName | JILL | |
| NPPES Provider ZIPCode | 700066530 | |
| NPPES Provider State | LA | |
| Specialty Description | Nephrology | |
| Total Claim Count | 3697.0 | |
| Distinct Opioid Count | 5.0 | |
| Opioid Claim Count | 319.0 | |
| Percent Opioid Claims | 8.63 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1952393795 |
| Last Name Of The Provider | LINDBERG |
| First Name Of The Provider | JILL |
| View All |
Similar Doctors
|
|
Dr. Sousan L. Zadeh, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sudhir K. Julka, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Binh P. Nguyen, MD |
|
|
Dr. Edwin L. Lamberth Jr., MD |
|
|
Dr. Steven A. Morris, MD |
|
|
Dr. Matthew K. Sanger, MD
This Doctor is OpenDoctor Recommended.
|